I agree with the PC results; to me its pretty clear the drug is having a dramatic effect on bone mets.
I just cannot for the life of me figure out where the hell their cash goes? And then there are other companies who seem to spend 1/10th of their spend and seem to progress more.
Its like their CEO/CFO think this is AMGEN...By looking at their pictures of their HQ, I think they think they are AMGN.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.